Evidence map›Paper›PMID 33253225›Full record

ArticlePloS one2020

Stimulation of the human mitochondrial transporter ABCB10 by zinc-mesoporphrin.

Melissa Martinez, Gregory A Fendley, Alexandra D Saxberg, Maria E Zoghbi

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Deciphering of SOX9 Functions in Pancreatic Cancer Cells.International journal of molecular sciences · 2025
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Melissa MartinezDepartment of Molecular Cell Biology, School of Natural Sciences, University of California Merced, Merced, California, United States of America.
Gregory A FendleyDepartment of Molecular Cell Biology, School of Natural Sciences, University of California Merced, Merced, California, United States of America.
Alexandra D SaxbergDepartment of Molecular Cell Biology, School of Natural Sciences, University of California Merced, Merced, California, United States of America.
Maria E ZoghbiDepartment of Molecular Cell Biology, School of Natural Sciences, University of California Merced, Merced, California, United States of America.ORCID 0000-0002-4206-4673
University of California, Merced · US

Funding

Molecular Mechanism of the Mitochondrial ABC Transporter ABCB10R15GM131289 · NIGMS · UNIVERSITY OF CALIFORNIA, MERCED · PI ZOGHBI, MARIA ELENA · 2018 to 2018
$442k
NIGMS NIH HHS R15 GM131289
6 · The paper itself

Abstract

Heme biosynthesis occurs through a series of reactions that take place within the cytoplasm and mitochondria, so intermediates need to move across these cellular compartments. However, the specific membrane transport mechanisms involved in the process are not yet identified. The ATP-binding cassette protein ABCB10 is essential for normal heme production, as knocking down this transporter in mice is embryonically lethal and accompanied by severe anemia plus oxidative damage. The role of ABCB10 is unknown, but given its location in the inner mitochondrial membrane, it has been proposed as a candidate to export either an early heme precursor or heme. Alternatively, ABCB10 might transport a molecule important for protection against oxidative damage. To help discern between these possibilities, we decided to study the effect of heme analogs, precursors, and antioxidant peptides on purified human ABCB10. Since substrate binding increases the ATP hydrolysis rate of ABC transporters, we have determined the ability of these molecules to activate purified ABCB10 reconstituted in lipid nanodiscs using ATPase measurements. Under our experimental conditions, we found that the only heme analog increasing ABCB10 ATPase activity was Zinc-mesoporphyrin. This activation of almost seventy percent was specific for ABCB10, as the ATPase activity of a negative control bacterial ABC transporter was not affected. The activation was also observed in cysteine-less ABCB10, suggesting that Zinc-mesoporphyrin's effect did not require binding to typical heme regulatory motifs. Furthermore, our data indicate that ABCB10 was not directly activated by neither the early heme precursor delta-aminolevulinic acid nor glutathione, downsizing their relevance as putative substrates for this transporter. Although additional studies are needed to determine the physiological substrate of ABCB10, our findings reveal Zinc-mesoporphyrin as the first tool compound to directly modulate ABCB10 activity and raise the possibility that some actions of Zinc-mesoporphyrin in cellular and animal studies could be mediated by ABCB10.

Indexed as

Adenosine TriphosphatasesAdenosine TriphosphateATP-Binding Cassette TransportersBiological TransportGlutathioneHemeHumansMesoporphyrinsMitochondriaMitochondrial Membrane Transport ProteinsZincABCB10 protein, humanAdenosine TriphosphatasesAdenosine TriphosphateATP-Binding Cassette TransportersGlutathioneHememesoporphyrin IXMesoporphyrinsMitochondrial Membrane Transport ProteinsZinc

Identifiers

PMID33253225
PMCPMC7703921
OpenAlexW3108254084

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.